Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
38%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
PPH
26
HOLDINGS
57%
ALSO IN FTXH
FTXH
49
HOLDINGS
27%
ALSO IN PPH
SECTOR DRIFT (PPH minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 12.1% | 8.3% | 8.3% |
|
MERCK & CO. INC. | 6.3% | 6.9% | 6.3% |
|
ABBVIE INC | 5.1% | 7.5% | 5.1% |
|
PFIZER INC | 4.9% | 7.3% | 4.9% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% | 6.1% | 4.5% |
PPH Overweight Relative to FTXH
|
ELI LILLY & CO | 13.1% |
 |
NOVARTIS AG-ADR | 7.8% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.9% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% |
 |
SANOFI-AVENTIS-ADR | 4.7% |
|
MCKESSON CORP | 4.6% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.5% |
|
CENCORA INC | 3.9% |
|
JOHNSON & JOHNSON | 3.8% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 3.0% |
PPH Underweight Relative to FTXH
|
GILEAD SCIENCES INC | -4.1% |
|
UNITED THERAPEUTICS CORP | -3.7% |
|
AMGEN INC | -3.7% |
|
BIOGEN IDEC INC | -3.7% |
|
VIATRIS, INC. | -3.4% |
|
REGENERON PHARMACEUTICALS | -3.2% |
|
MEDPACE HOLDINGS, INC. | -2.6% |
 |
JAZZ PHARMACEUTICALS PLC | -2.5% |
|
PFIZER INC | -2.4% |
|
ABBVIE INC | -2.4% |